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Abstract
Background: The zoonosis bovine tuberculosis (TB) is known to be responsible for a considerable proportion of
extrapulmonary TB. In Mozambique, bovine TB is a recognised problem in cattle, but little has been done to
evaluate how Mycobacterium bovis has contributed to human TB. We here explore the public health risk for bovine
TB in Maputo, by characterizing the isolates from tuberculous lymphadenitis (TBLN) cases, a common manifestation
of bovine TB in humans, in the Pathology Service of Maputo Central Hospital, in Mozambique, during one year.
Results: Among 110 patients suspected of having TBLN, 49 had a positive culture result. Of those, 48 (98 %) were
positive for Mycobacterium tuberculosis complex and one for nontuberculous mycobacteria. Of the 45 isolates
analysed by spoligotyping and Mycobacterial Interspersed Repetitive Unit – Variable Number Tandem Repeat
(MIRU-VNTR), all were M. tuberculosis. No M. bovis was found.
Cervical TBLN, corresponding to 39 (86.7 %) cases, was the main cause of TBLN and 66.7 % of those where from HIV
positive patients.
We found that TBLN in Maputo was caused by a variety of M. tuberculosis strains. The most prevalent lineage was
the EAI (n = 19; 43.2 %). Particular common spoligotypes were SIT 48 (EAI1_SOM sublineage), SIT 42 (LAM 9), SIT 1
(Beijing) and SIT53 (T1), similar to findings among pulmonary cases.
Conclusions: M. tuberculosis was the main etiological agent of TBLN in Maputo. M. tuberculosis genotypes were
similar to the ones causing pulmonary TB, suggesting that in Maputo, cases of TBLN arise from the same source as
pulmonary TB, rather than from an external zoonotic source. Further research is needed on other forms of
extrapulmonary TB and in rural areas where there is high prevalence of bovine TB in cattle, to evaluate the risk of
transmission of M. bovis from cattle to humans.
Background
Tuberculosis (TB) ranks as the second leading cause of
death from a single infectious agent, after the human
immunodeficiency virus (HIV) [1]. In 2013, an estimated
9 million people developed TB and 1.5 million died from
the disease, from whom 360 000 were HIV positive [1].
The African continent accounts for one quarter of all
TB cases in the world and also has the highest rates of
cases and deaths relative to population [1].
Mozambique is one of the high burden TB and HIV
countries with a prevalence of HIV infection in adults of
11.5 % [2] and an estimated TB prevalence of 559 per
100 000 population. Fifty six percent of the TB patients
in Mozambique are estimated to be HIV positive [1].
Among all reported TB cases in 2013, 9.8 % were extra-
pulmonary [1].
TB is caused by bacteria of the Mycobacterium tuber-
culosis complex. The Mycobacterium tuberculosis and
the Mycobacterium bovis are the primary agents of the
disease in humans and cattle respectively.
The TB epidemic in Mozambique is caused by an ex-
tensive diversity of M. tuberculosis spoligotypes with
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predominance of LAM, EAI, T and Beijing lineages [3]. To
our knowledge, no information regarding lineages in-
volved in extrapulmonary TB in Mozambique is available.
Bovine TB, caused by M. bovis, is the main zoonotic
disease caused by mycobacteria, affecting cattle, other
domesticated animals and several free or captive wildlife
species. In Mozambiquethe overall prevalence of BTB in
cattle is 13.6 % [4], varying from 0.98 % in Massingir [5]
to 39.6 % in the Govuro district [6]. Little is known
about the impact of bovine TB as a human disease in
low income countries, particularly in HIV positive pa-
tients, including in Mozambique.
In Africa, bovine TB accounts for an estimated median
proportion of 2.8 % (range 0 %–37.7 %) of all reported
human TB cases [7].
Bovine TB is spread to humans, typically by ingestion
of unpasteurized milk or contaminated meat, causing
extrapulmonary TB, but can also be transmitted by in-
halation of aerosols causing pulmonary TB [8, 9]. Several
studies have detected M. bovis in tuberculous lymph-
adenitis (TBLN) cases [10–15], being the most common
among all extrapulmonary TB cases.
In the present study, we explored the public health
risk for bovine TB in Maputo, capital of Mozambique,
by characterizing the isolates from TBLN cases, during
one year, in the Pathology Service of Maputo Central
Hospital.
Results
Demographic characteristics
Participants were recruited from July 2013 to July 2014
at the Pathology Service of Maputo Central Hospital,
Mozambique. A total of 110 patients, suspected of hav-
ing TBLN, were recruited to participate in the study
(Fig. 1). From those patients, 45 isolates were analysed
by genotyping methods, one isolate per patient. The
demographic information of the 45 patients is summa-
rized in Table 1. Among all, 28 (62.2 %) were male while
17 (37.8 %) were female.
The patients’ median age was 33 years (11.1 SD) with
a range of 18–75 years. Stratification according to age
showed that 39 (86.7 %) of the patients were aged 18–45,
while 6 (13.3 %) were above 46 years.
Fifteen (33.3 %) patients had been previously treated
for TB and 15 (33.3 %) had had previous contact with
TB patients.
Site of sample collection
Cervical lymphadenitis was the main cause of TBLN in
Maputo. Of the lymph node samples 39 (86.7 %) were
collected from the cervical region, two (4.4 %) from
axillary site and one (2.2 %) from inguinal region. Other
sites were breast, chest and thigh (one case, 2.2 % from
each site).
Fig. 1 Chart showing patient’s recruitment, culture, identification and resistance results
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HIV serology and drug resistance
Among the 45 patients, 30 (66.7 %) were HIV positive
(19 males and 11 females), nine (20.0 %) were HIV nega-
tive and six (13.3 %) were not tested for HIV. Of the cer-
vical TBLN cases, 26 (66.7 %) were HIV positive patients.
Of the 61 patients with negative or contaminated culture
results, 39 (63.9 %) were HIV positive, nine (14.8 %) were
HIV negative and 13 (21.3 %) were not tested for HIV. No
statistical association was found between HIV serology
and cervical TBLN.
In Mozambique, being a mine worker is considered a
risk factor for HIV [16], information related to previous
work in South African mines was collected; among all
positive cultures, four were from mine workers, of them
two were HIV positive and two HIV negative.
Two patients, EBOV 13–23 (27 years, Lineage T1,
SIT 53) and EBOV 13–29 (28 years, Lineage Beijing, SIT
1), both males, HIV positive and not previously treated for
TB, were diagnosed with multidrug resistant (MDR) TB,
defined as simultaneous resistance to isoniazid and rifam-
picin (Fig. 2).
Culture and cytology results
Among all, 49 patients had a positive mycobacterial cul-
ture, giving a culture positivity rate of 44.5 %. Of them, 48
isolates were identified as M. tuberculosis complex and
one as nontuberculous mycobacteria (NTM; 32 years,
male, HIV positive). From the 59 culture negative patients
there were an additional 15 (25.4 %) cases Ziehl Neelsen
Table 1 Demographic data of the 45 patients that were
analysed by genotyping methods
Category Total isolates n (%)
Sex Male 28 (62.2)
Female 17 (37.8)
Age 18–45 39 (86.7)
+45 6 (13.3)
HIV sero-status Positive 30 (66.7)
Negative 9 (20)
Not tested for HIV 6 (13.3)
Previously TB treatment Yes 15 (33.3)
No 30 (66.7)
Contact with TB patients Yes 15 (33.3)
No 30 (66.7)
Fig. 2 MIRU-VNTR and Spoligotyping dendrogram of the 44M. tuberculosis strains from TBLN isolates from Maputo. The roman numbers indicates
the MIRU-VNTR cluster in this study. a) Multidrug resistant isolates
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(ZN) positive on cytology (morphological evidence of
mycobacterial infection). In the remaining 44 patients,
based on cytology, there was a specific diagnosis other
than mycobacterial infection.
Among the 48 culture confirmed TB cases, 45 isolates
were analysed by spoligotyping and Mycobacterial Inter-
spersed Repetitive Unit-Variable Number Tandem Repeat
(MIRU-VNTR). For the remaining three isolates and for
the NTM, DNA was not available, because there was no
growth during the re-culture procedure (Fig. 1).
Mixed infection isolate
In patient EBOV 13–19 (male, 59 years, HIV positive), a
spoligotype SIT 2117 (Manu 2; all spacers present except
spacers 9, 10, 33 and 43) was observed (Additional file
1). This type of pattern may correspond to a mixed in-
fection, due to concomitant Beijing and Euro-American
lineage strains (the latter comprising H, LAM, X, and T
lineages per spoligotyping defined clades). A mixed in-
fection was defined as the occurrence of strains with
different 24-loci MIRU-VNTR patterns at two or more
loci in the same sample. We further investigated this iso-
late; by spoligotyping we could observe different inten-
sities of the spacers in the spoligotyping pattern (Fig. 3)
and by MIRU-VNTR we could observe double alleles in
three different locus (MIRU26, Mtub21, and Mtub30),
confirming a mixed infection pattern. Since it was con-
firmed as a mixed infection, the isolate EBOV 13–19
was excluded from further genotypic analysis.
Spoligotyping
Spoligotyping is a simple, rapid and cost effective
method for simultaneous detection and typing of the M.
tuberculosis complex. It is the method of choice for
strains with less than five copies of the insertion sequence
IS6110, like M. bovis strains, which usually contain only
one or two IS6110 copies [17–19]. By spoligotyping,
M. tuberculosis isolates are characterized by the ab-
sence of spacers 33–36, while M. bovis usually lack
spacers 39–43 [20].
Spoligotyping was performed on 45 isolates. Of them,
all were defined as M. tuberculosis and no M. bovis was
found.
Among the 44 isolates (excluding the mixed infection
isolate), 23 spoligopatterns were obtained. Three pat-
terns corresponded to orphan strains that were unique
in the SITVIT2 database, as opposed to 20 patterns from
41 patients that corresponded to shared-types (SITs), i.e.
an identical pattern shared by two or more patients
worldwide (within this study, or matching another strain
in the SITVIT2 database), as shown in Table 2.
For each isolate, their binary/octal description, their
lineages and SITs are summarized in Table 2. Four SITs
(containing seven isolates) were newly created either
within the present study or after a match with an orphan
in the database. Nine patterns were in clusters, contain-
ing 30 isolates (2 to 6 isolates per cluster), amounting to
an overall clustering rate of 68.2 % (30/44).
As shown in Table 2, the most common spoligotypes
found in this study were SIT48 (East African-Indian_
Somalia; EAI1_SOM) with six isolates; SIT1 (Beijing
lineage) and SIT42 (Latin America Mediterranean;
LAM 9) with five isolates each and SIT53 (T1) with
four isolates. The most common lineage was the EAI
(n = 19; 43.2 %).
MIRU-VNTR results
Figure 2 shows the MIRU-VNTR clusters and respective
spoligotyping results obtained in this study. Among the
44 isolates analysed by MIRU-VNTR, a wide variety of
patterns were observed. Only three clusters of two iso-
lates each were formed, cluster I (Lineage H3, SIT 4094);
cluster II (Beijing lineage, SIT 1); cluster III (Lineage
EAI1_SOM, SIT 48). The remaining patterns were
unique, i.e., did not cluster with any other isolate within
this study.
Phylogenetic analysis
Minimum Spanning Trees (MST) depicts evolutionary
relationships between the M. tuberculosis genotypes in
our study using spoligotyping and/or 24-loci MIRU-
VNTR typing. The MST based on spoligotypes alone
(Additional file 2A) showed isolated relatively well clus-
tered into their respective lineages/sublineages. Isolates
belonging to Beijing, EAI lineage and LAM were rather
well organized in the three MSTs. However, on the MST
based on 24-loci MIRU-VNTR alone (Additional file 2B),
one may notice that the isolate represented by SIT254 or
24-MIT Or16 (lineage T5-RUS1), was better correlated
with isolates belonging to LAM lineage. Furthermore, the
isolate represented by SIT4 or 24-MIT Or30 (Unknown
lineage) was also close to LAM lineage strains. Contrary
to the MST based on spoligotypes alone (Additional
file 2A) and on spoligotypes + 24-loci MIRU-VNTR
(Additional file 2C), the MST based on 24-loci MIRU-
VNTR alone (Additional file 2B) depicted a similarity be-
tween isolates belonging to Beijing lineage and the unique
isolate (SIT952 or 24-MIT Or01) representing CAS1-
Fig. 3 Spoligotyping pattern of the strain EBOV 13–19. The picture shows different intensities of the spacers
Viegas et al. BMC Microbiology  (2015) 15:268 Page 4 of 10
Delhi lineage. For a better data mining of isolates related
to 24-loci MIRU-VNTR information, one can refer to
Additional file 1 showing the whole picture of association
between the various genotypes.
Discussion
In this study we presented for the first time the lineages
of M. tuberculosis complex causing extrapulmonary TB
in Maputo, Mozambique. Extrapulmonary TB is re-
ported in 11.6 % of all TB cases in the country [1], the
majority of them being TBLN.
Several studies have shown correlation between HIV
infection and TBLN [21–23]. The synergies between TB
and HIV infection [24, 25] have resulted in an increase
in the incidence of TBLN and have further complicated
TB control. In this study, the high prevalence of HIV
positive patients (66.7 %) among TBLN cases, might
suggest a rising trend of HIV infection associated with
TBLN in Maputo. A possible explanation for the high
rate of HIV among TBLN cases might be confounders
associated with HIV. However, the numbers related to
previous mine working did not allow the interpretation
of potential associations with HIV and information re-
lated to alcohol, drug abuse, ex-imprisonment or smok-
ing was not collected.
Laboratory detection of bovine TB is a challenge, par-
ticularly in low income countries. Microscopy for myco-
bacteria on the FNA is the initial diagnostic procedure
for lymphadenitis in Mozambique; although it does not
differentiate between M. tuberculosis and M. bovis, it is
Table 2 Shared Types and orphans description in the study, their percentage and lineage within the study
*Newly created SITs, either within the present study or after a match with an orphan in the database
**Orphans, unique in the SITVIT2 database
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considered a reliable TBLN diagnostic method, including
in HIV positive individuals [26–29]. Molecular typing
methods for M. tuberculosis complex detection on FNA
specimen are costly and require technical expertise,
therefore, are not implemented as a routine method in
the country, making the detection of bovine TB difficult.
In this study, among all TBLN suspects, 43.6 % were
confirmed to have M. tuberculosis complex strains on
culture and one was NTM, no M. bovis was found,
showing that M. tuberculosis is the main cause of TBLN
in Maputo. The additional 15 (25.4 %) cases that were
positive on cytology might be due to infection by either
M. tuberculosis complex or NTM which were not de-
tected by culture.
These results are compatible with two studies con-
ducted in the North of Ethiopia, where no M. bovis was
detected and M. tuberculosis was identified as the main
etiological agent in TBLN cases [30, 31]. On the other
hand, another study conducted in Guji zone of Ethiopia,
an area inhabited by pastoral and agro-pastoral commu-
nities whose livelihood is based on livestock production,
among 173 isolates, three were M. bovis; the same study
analysed 39 livestock samples, where one M. tuberculosis
was isolated in camels, suggesting transmission between
livestock and humans in this pastoral area. This last
study emphasises the importance of an appropriate study
area, where risk factors, including close contact between
humans and livestock, and consumption of raw milk
and meat by the communities, are present. This can be
one of the reasons for the absence of M. bovis in the
present study.
By spoligotyping, the main lineages of TBLN were the
EAI, Beijing; LAM and T1; and the major SITs, were
SIT48, SIT1, SIT42 and SIT53. These genotypes are also
predominant in pulmonary cases in Mozambique [3],
indicating that there are no differences in the population
of strains in pulmonary and extrapulmonary cases. Simi-
larities between pulmonary and extrapulmonary cases
were observed in other countries, i.e. Ethiopia [31],
Thailand [32], Madagascar [33] and Brasil [34].
In African countries, little is known about the com-
mon lineages responsible for extrapulmonary TB. A
study conducted in the neighbouring South Africa, in
children, showed similarities with our findings, stressing
the proximity between the two countries. In the South
African study, 21.2 % of the M. tuberculosis isolates
belonged to the LAM lineage, and 20 % to the Beijing
lineages [35]. In another study performed in Ethiopia,
spoligotyping revealed that the most common spoligo-
types in extrapulmonary TB were SIT54, SIT53, and
SIT149 [36]; SIT54, Lineage T1 was also found to be
common in TBLN cases from the present study.
The ancestral EAI lineage, most predominant in this
study (42.2 %), and one of the prevalent lineages in
pulmonary TB cases in Mozambique, with a predomin-
ance of 29.7 % [3]; is considered to be endemic in the
Southern region of India [37, 38]. The migration link be-
tween India, particularly South India, and Mozambique
arisen since the second half of the 19th century, when
Indian traders practised the trade routes of the Indian
Ocean, for transnational connections. The high preva-
lence of EAI lineages in Maputo might represent an in-
dication of TB transmission between the two countries.
The Beijing lineage was also found to be one of the
most common lineages in TBLN cases from this study.
In South Africa, it was the second most common spoli-
gotype found in extrapulmonary cases [35] and in
Thailand, Beijing lineage was reported to be the most
predominant in extrapulmonary TB cases, with 56 [39]
and 57.9 % [40]. Further research is needed to evaluate
whether Beijing lineage has any particular association
with extrapulmonary TB.
We have also shown an association between the
Beijing lineage and HIV infection [41], although in this
study, perhaps because of the sample size, it was not pos-
sible to find any relationship between a particular lineage
and HIV infection. Furthermore, analysis of the spoligotyp-
ing lineages did not show any association with a particular
clinical expression of the disease (data not shown).
Based on MIRU-VNTR analysis, we could observe a
wide diversity of patterns, within strain lineages, show-
ing that TB lymphadenitis in Maputo is not caused by a
particular strain but by a wide variety of strains, an indi-
cation that risk factors for developing TBLN are rather
associated with host than M. tuberculosis strain.
In this study, a mixed M. tuberculosis complex infec-
tion was detected in one case of TBLN. Mixed M. tuber-
culosis infections, a potential obstacle for tuberculosis
treatment and control, occurs when an individual is sim-
ultaneously infected with more than one strain of M.
tuberculosis complex. In high TB prevalence settings,
mixed infections are frequent, implying high reinfection
rates and the absence of efficient protective immunity
conferred by the initial infection [42].
In pulmonary TB cases from Mozambique, we have
shown mixed infection with a Beijing and non-Beijing
strain in two out of five Manu strains [3].
In South Africa, a study conducted in Cape Town,
showed that 57 % of patients infected with a Beijing
strain were also infected with a non-Beijing strain [42].
Other countries have also reported mixed infection within
different strains from the M. tuberculosis complex, i.e.
Botswana [43], China [44], Taiwan [45].
In this study, no M. bovis was found. In low income
countries there are no effective animal TB control pro-
grammes and surveillance, and the epidemiological and
public health aspects of infection due to bovine TB are
scarce [7–9]. This situation is aggravated by the presence
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of additional risk factors such as human behaviour and
the high prevalence of HIV infections [8, 9, 13]. In African
countries, a median of 2.8 % (range 0 %–37.7 %) of all
humans cases of TB are estimated to be caused by M.
bovis [7]. Variances on prevalence are observed in differ-
ent sites; those differences might be influenced by sam-
pling, study area and diagnostic methods. Prevalence
varies from; 17 and 4.4 % in Ethiopia [12, 46], 16 in
Tanzania [47], 7 in Uganda [14], 3 in Ghana [48] and
15.38 % in Nigeria [49]. The genotyping findings from
this study and the findings in pulmonary cases [3] indi-
cate that the overall contribution of M. bovis to human
TB in Maputo is minor. However, the present study has
certain limitations. The small number of positive cases on
culture might have reduced the chances of finding M. bovis
as well as the statistical power and have affected the con-
clusions regarding the significance of the different variables
and M. tuberculosis lineages. Furthermore, patients from
this study are from urban or peri-urban areas of Maputo
where livestock and consumption of unpasteurized milk is
minor, thus, exposure to M. bovis is less.
The occurrence of zoonotic TB is greatly dependent
on the presence of bovine TB in cattle. M bovis in cattle
is very frequent in certain areas of Mozambique; a re-
cent publication has demonstrated a high prevalence of
bovine TB in cattle of 39.6 % (95 % CI 36.8–42.5) in one
particular district of Mozambique [6]. Another study
carried out in 2008 in the same region reported a bovine
TB prevalence rate of 61.9 % (95 % CI: 55.8–67.8) [50].
Further research is needed on cases of abdominal TB
and other forms of TB, and in pastoral areas, where the
prevalence of bovine TB in cattle is known to be high in
order to have a better answer about the public health
importance of this zoonotic disease in Mozambique.
Conclusions
M. tuberculosis was the main etiological agent of TBLN
in Maputo. M. tuberculosis lineages in TBLN were similar
to the ones previously reported to cause pulmonary TB,
suggesting that in Maputo, cases of TBLN arise from the
same source as pulmonary TB, rather than from an exter-
nal zoonotic source.
Methods
Ethical considerations
Institutional permission to conduct the study was obtained
from the National Bioethics Committee of the Ministry of
Health in Maputo, Mozambique, reference number 216/
CNBS/14. The patients were included after understanding
the study and had signed an informed consent.
Study setting
In Mozambique there are three pathology services, in
Maputo, Beira and Nampula, each of them responding
for the South, Central and North region of the country
respectively.
The Pathology Service of Maputo Central Hospital is
the only referral site in Maputo for diagnosing TBLN,
patients suspected of mycobacterial infection were re-
ferred from different health units for diagnosis. During
the study period, they have received 677 patients sus-
pected of TBLN, of whom, 110 (16.2 %) were included
in the study. The swellings observed were cervical, axil-
lary or from other sites, either as a unilateral single or
multiple mass or masses. Fistula formation could also
been seen in certain cases.
Patients who also had pulmonary involvement were
considered as extrapulmonary TB in our analysis.
Patients and specimens
This study was conducted from July 2013 to July 2014 at
the Pathology Service of Maputo Central Hospital in
Maputo, Mozambique. A total of 110 patients with sus-
pected TBLN and subjected to FNA were included in
the study. For each patient, a questionnaire was applied.
Demographic and clinical information of the partici-
pants was collected by trained clinical nurses using a
pre-tested questionnaire. HIV test results were collected
from the medical records after obtaining written consent
from the patients. Patients without HIV results were
advised for testing and that was only performed after pa-
tients consent.
Only patients suspected of TBLN that consented and
could give at least 0,1 ml of sample were recruited to
participate in the study.. That was applied in order to
have enough material for the routine smear performed
in the unit, direct microscopy using conventional ZN
staining and cytology, and subsequent assays to be per-
formed within the study.
All material was collected by a Specialist Physician
from the Pathology Service, using the FNA Cytology
procedure in use in the Unit, as described below.
Collection of lymph node aspirate and staining
Lymph node aspirate was collected as a routine proced-
ure in the Pathology Service for all suspected of having
TBLN. Briefly FNA was performed from a swollen
superficial lymph node by using a sterile 23-gauge nee-
dle with an attached 10 ml syringe. The overlying area
was cleaned with 70 % alcohol. Then the node was
punctured by developing a negative pressure in the syr-
inge. Multiple in and out passes were made by the nee-
dle without exiting the node. After removing the needle,
in all cases, special ZN staining for acid fast bacilli was
done and cytology was performed. The remaining aspi-
rated sample was referred to The National TB Reference
Laboratory for culture.
Viegas et al. BMC Microbiology  (2015) 15:268 Page 7 of 10
Culture and identification methods
The cultures were performed using N-Acetyl-L-Cyst-
eine-Sodium Hydroxide (NALC-4 % NaOH) decontam-
ination method as previously described [51] and inoculated
into three culture media: 1) Liquid culture (BD BBL™
MGIT™ Mycobacteria Growth Indicator Tube), 2)
Löwenstein-Jensen slants (BD BBL™ Lowenstein-Jensen
Medium) and 3) Stonebrinkslants (in house made-). All
tubes were incubated at 37 °C..
All positive cultures were accordingly identified as M. tu-
berculosis complex or not using SD BIOLINE TB Ag
MPT64 rapid test according to manufacturer’s instructions.
Isolates identified as M. tuberculosis complex were
subjected to Line Probe Assay, GenoType MTBDRplus
(Hain, Nehren, Germany), for detection of MDR TB as
previously described [52].
Spoligotyping
Standard spoligotyping [53] was performed generally as
described by Kamerbeek and colleagues. Spoligotyping
results were analysed and dendograms created using the
BioNumerics Software ver. 7.5 (Applied Maths, Kortrijk,
Belgium).
Spoligotyping patterns were also compared with the
ones existing in the international Spoligotyping database
SITVIT2, which is an updated version of SITVITWEB [54].
Shared international types (SITs) that were newly-created
either within the present study or after a match with an
orphan in the database, were assigned a new SIT number.
Mycobacterial Interspersed Repetitive Unit – Variable
Number Tandem Repeat (MIRU-VNTR) analysis
Standardized 24-loci MIRU-VNTR typing [55] was per-
formed using the MIRU-VNTR typing kit (Genoscreen,
Lille, France). The PCR-products were run with 1200 LIZ
size standard (GeneScan, Applied Biosystems) on ABI3500
sequencers. Sizing of the PCR-fragments and assignments
of MIRU-VNTR alleles were done with the GeneMapper
software version 4.1 (Applied Biosystems) according
to the manufacturers’ instructions. MIRU-VNTR were
also compared with SITVIT2, and newly created 24-
loci MIRU-VNTR International Types (24-MITs) were
assigned.
HIV testing
HIV testing was performed at the Sanitary Unit of enrol-
ment according to the recommendations by the Ministry
of Health, Mozambique. Two rapid HIV tests were used
sequentially, Unigold Recombinant HIV (Trinity Biotech,
Wicklow, Ireland) and Determine HIV-1/2 (Abbot,
Tokyo, Japan). Samples were tested first with Determine
and reported only when negative. Positive samples were
confirmed with Unigold. All tests were performed and
interpreted according to the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed on Data Analysis and
Statistical Software (STATA), version 13. Descriptive sta-
tistics was used for summarizing demographics data.
Categorical variables were presented using frequencies
and percentages. Bivariate analyses were performed for
TB lymphadenitis versus HIV status, HIV status x lineage
using chi-square test. Multinomial Logistic regression
model were created with TB lymphadenitis as outcome
and sex age and HIV status included as predictors. Inter-
actions were tested and all were not statistically signifi-
cant. Since no interactions were statistically significant,
they are not presented.
Phylogenetic analysis
Phylogenetic relationships were calculated using Multiple-
Locus Variable-number tandem repeat Analysis (MLVA)
Compare software version 1.03 (Genoscreen and Ridom
Bioinformatics). MST were drawn from spoligotyping and
24-loci MIRU-VNTR typing, to better visualize probable
relationships and dependencies between isolates. The
phylogenetic trees connect each genotype based on degree
of changes required to go from one allele to another (the
distance numbers are visible on each edge). Solid black
line denotes one unique change between two patterns,
while solid grey line denotes 2 changes, bold dashed line
denotes 3 changes, and thin dotted line represents 4 or
more changes. The size of the circle is proportional to the
total number of isolates. The colour of the circles indicates
the phylogenetic lineage to which the specific pattern be-
longs. International Types (IT) numbers appear inside
nodes. Both SIT and 24-MIT appeared inside nodes of the
tree combining spoligotypes and 24-loci MIRU-VNTR.
Additional files
Additional file 1: Full description of MIRU-VNTR and spoligotyping
analysis in this study. *Newly created 12, 15, or 24-MIRU International
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